In order to better understand the etiology of human IR and its progression to T2D and determine the clinical efficacy of Nrf2 inducers, further cohort studies would be required to characterize the interaction of genetic and environmental factors, including obesity and aging (Figure 7). The gene discussed is NFE2L2; the disease is Obesity.